此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Human Genomic Population Structure and Phenotype-genotype Variation in ADME Genes in Four Populations

2017年5月9日 更新者:Estella S. Poloni

Exploratory Study of the Variability, in Five Human Populations, of ADME (Administration, Distribution, Metabolism, Excretion) Genotypes and Phenotypes After the Intake of the "Geneva Micrococktail"

Physicians know that their patients can react differently to the same medical treatment: for some of them, the drug will prove inefficient, whereas for others it might provoke side-effects, sometimes rather serious. Such differences in response to drug intake are due to several factors, of which molecular variations in specific genes, named " ADME " (Absorption, Distribution, Metabolism, Excretion). This project aims at investigating the evolutionary mechanisms responsible for the diversity of ADME genes in human populations. Because of their role at the interface between the organism and its chemical environment, ADME genes are likely targets of recent selective pressures linked to changes in the environments in which humans evolved, such as changes in dietary habits for instance.

The aim of this project is to study the diversity of ADME genes and of their expression in five populations located along a latitudinal axis that extends from East Africa to Central Europe, passing through the Arabian Peninsula and the Mediterranean area, so as to take into account environmental factors that might have influenced the evolution of this diversity. This project is thus intended to evidence the evolutionary mechanisms that shaped genomic regions that are functionally important from the clinical and epidemiological point of view. Moreover, it will allow us to extend the knowledge of human molecular diversity and its evolution to a key-region of the peopling history of our species.

研究概览

地位

完全的

条件

研究类型

介入性

注册 (实际的)

367

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Addis Ababa、埃塞俄比亚、P.O.Box 9086
        • Addis Ababa University/College of Health Sciences
      • Alexandroupolis、希腊、68100
        • Democritus University of Thrace/School of Health Sciences/University Campus, Dragana
      • Praha 2、捷克语、128 43
        • Charles University in Prague/Faculty of Science/Department of Anthropology and Human Genetics
      • Muscat、阿曼、P. O. Box 50
        • Sultan Qaboos University/College of Medicine and Health Sciences/Department of Pharmacology

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 50年 (成人)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Women and men in good health
  • Aged between 18 and 50 years
  • Students or staff in the Academic Institutions where sampling will take place
  • With the 2 parents and four grand-parents born to the population;
  • Able to provide informed consent

Exclusion Criteria:

  • Pregnant or breastfeeding women; or women that consider that being pregnant is a possibility;
  • Allergic to one of the compounds included in micrococktail (Caffeine, Bupropion, Flurbiprofen, Omeprazole, Dextromethorphan, Midazolam, and Fexofenadine);
  • Pedigree related to another volunteer participant (siblings, cousins, uncles/aunts, nephews, etc.);

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:基础科学
  • 分配:非随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Healthy volunteers in Ethiopia
Phenotype and genotype of enzymes involved in drug metabolism in Ethiopia population
finger-tip blood drop : enzymatic activities assessed by specific single point concentration ratios after oral intake of the Geneva micrococktail made of : CYP1A2: paraxanthine/caffeine CYP2B6: 4-hydroxybupropion/bupropion CYP2C9: 4-hydroxyflurbiprofen/flurbiprofen CYP2C19: 5-hydroxyomeprazole/omeprazole CYP2D6: dextrorphan/dextromethorphan CYP3A4: 1-hydroxymidazolam/midazolam
DNA sampling from a saliva sample
实验性的:Healthy volunteers in Oman
Phenotype and genotype of enzymes involved in drug metabolism in Oman population
finger-tip blood drop : enzymatic activities assessed by specific single point concentration ratios after oral intake of the Geneva micrococktail made of : CYP1A2: paraxanthine/caffeine CYP2B6: 4-hydroxybupropion/bupropion CYP2C9: 4-hydroxyflurbiprofen/flurbiprofen CYP2C19: 5-hydroxyomeprazole/omeprazole CYP2D6: dextrorphan/dextromethorphan CYP3A4: 1-hydroxymidazolam/midazolam
DNA sampling from a saliva sample
实验性的:Healthy volunteers in the Czech Republic
Phenotype and genotype of enzymes involved in drug metabolism in Czech Republic population
finger-tip blood drop : enzymatic activities assessed by specific single point concentration ratios after oral intake of the Geneva micrococktail made of : CYP1A2: paraxanthine/caffeine CYP2B6: 4-hydroxybupropion/bupropion CYP2C9: 4-hydroxyflurbiprofen/flurbiprofen CYP2C19: 5-hydroxyomeprazole/omeprazole CYP2D6: dextrorphan/dextromethorphan CYP3A4: 1-hydroxymidazolam/midazolam
DNA sampling from a saliva sample
实验性的:Healthy volunteers in Greece
Phenotype and genotype of enzymes involved in drug metabolism in Greek population
finger-tip blood drop : enzymatic activities assessed by specific single point concentration ratios after oral intake of the Geneva micrococktail made of : CYP1A2: paraxanthine/caffeine CYP2B6: 4-hydroxybupropion/bupropion CYP2C9: 4-hydroxyflurbiprofen/flurbiprofen CYP2C19: 5-hydroxyomeprazole/omeprazole CYP2D6: dextrorphan/dextromethorphan CYP3A4: 1-hydroxymidazolam/midazolam
DNA sampling from a saliva sample

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Frequencies of genotypes and haplotypes of genes involved in drug responses (240,000 Single Nucleotide Polymorphisms) in 4 human populations : 100 Ethiopian, 100 Omani, 100 Czech and 100 Greek
大体时间:through study completion, an average of 2 years
Estimation of genotype/allele/haplotype frequencies of variants in genes involved in drug responses
through study completion, an average of 2 years
Activities of 6 cytochrome P450 enzymes and P-gp in 4 human populations : 100 Ethiopian, 100 Omani, 100 Czech and 100 Greek
大体时间:through study completion, an average of 2 years
Estimation of frequency distributions of classes of drug metabolizers (metabolizers' profiles: slow/normal/rapid)
through study completion, an average of 2 years

次要结果测量

结果测量
措施说明
大体时间
Comparison of frequency distributions of variants in genes involved in drug responses and of associated metabolizers' profiles in 4 human populations : 100 Ethiopian, 100 Omani, 100 Czech and 100 Greek
大体时间:through study completion, an average of 3 year
Estimation of indices of population genetic/phenotypic diversity and differentiation (expected heterozygosity, Fst). Inferences on the evolutionary mechanisms explaining the estimated diversity among and between populations.
through study completion, an average of 3 year

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 学习椅:Estella S. Poloni, Dr、University of Geneva/Department of Genetics and Evolution

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2015年11月1日

初级完成 (实际的)

2017年4月1日

研究完成 (实际的)

2017年4月1日

研究注册日期

首次提交

2016年5月11日

首先提交符合 QC 标准的

2016年5月27日

首次发布 (估计)

2016年6月3日

研究记录更新

最后更新发布 (实际的)

2017年5月10日

上次提交的符合 QC 标准的更新

2017年5月9日

最后验证

2017年5月1日

更多信息

与本研究相关的术语

关键字

其他研究编号

  • 15-169

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅